Search for: "Matter of Noonan" Results 141 - 160 of 304
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Mar 2009, 9:53 pm
Noonan -- The Court of Appeals for the Federal Circuit occupies a unique place in the Federal appellate system. [read post]
14 Apr 2010, 10:29 pm by Patent Docs
Noonan -- It is a bedrock principle of patent practice that the U.S. [read post]
19 Aug 2010, 11:24 am by Jon Sands
In dissent, Noonan argues that enough is enough. [read post]
23 Mar 2012, 4:48 am by Lawrence B. Ebert
Patentable Subject Matter for Diagnostic Methods After In re Bilski, 3 Case W. [read post]
5 Oct 2022, 8:12 pm by Patent Docs
Noonan -- The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) Final Written Decision (FWD) in an inter partes review (IPR) that Mylan Pharmaceuticals failed to show the claims of U.S. [read post]
1 Sep 2020, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit recently applied well-established principles of obviousness in affirming the Patent Trial and Appeals Board's invalidation of several patents related to antifungal formulations in Anacor Pharmaceuticals, Inc. v. [read post]
20 Apr 2019, 3:19 pm by Patent Docs
MBHB attorneys and Patent Docs authors Kevin Noonan and Donald Zuhn, and MBHB attorneys Josh Rich, Lisa Hillman, Sarah Fendrick, John Conour, Nate Chongsiriwatana, and Nicole Grimm will provide presentations on the following topics: • Updates on Subject Matter Eligibility Analysis • Patenting Repurposed Drugs • Antibody Patenting after Amgen v. [read post]
23 Mar 2019, 7:34 pm by Patent Docs
MBHB attorneys and Patent Docs authors Kevin Noonan and Donald Zuhn, and MBHB attorneys Josh Rich, Lisa Hillman, Sarah Fendrick, John Conour, Nate Chongsiriwatana, and Nicole Grimm will provide presentations on the following topics: • Updates on Subject Matter Eligibility Analysis • Patenting Repurposed... [read post]
6 Apr 2019, 7:57 pm by Patent Docs
MBHB attorneys and Patent Docs authors Kevin Noonan and Donald Zuhn, and MBHB attorneys Josh Rich, Lisa Hillman, Sarah Fendrick, John Conour, Nate Chongsiriwatana, and Nicole Grimm will provide presentations on the following topics: • Updates on Subject Matter Eligibility Analysis • Patenting Repurposed Drugs • Antibody Patenting after Amgen v. [read post]
21 Jun 2023, 9:01 pm by Patent Docs
Noonan -- Responsive to the letter from Judge Pauline Newman's counsel sent June 15th (see "Judge Newman Matter Continues"), the Special Committee directing the Federal Circuit's inquiry regarding Judge Newman's fitness for continued service on the Court (consisting of Chief Judge Moore, former Chief Judge Prost, and Judge Taranto) issued a per curiam response. [read post]
30 Mar 2019, 8:51 pm by Patent Docs
MBHB attorneys and Patent Docs authors Kevin Noonan and Donald Zuhn, and MBHB attorneys Josh Rich, Lisa Hillman, Sarah Fendrick, John Conour, Nate Chongsiriwatana, and Nicole Grimm will provide presentations on the following topics: • Updates on Subject Matter Eligibility Analysis • Patenting... [read post]
25 Jan 2024, 8:25 pm by Patent Docs
(holding that claim construction was a matter of law to be reviewed de novo by the Federal Circuit; but see Teva Pharma. [read post]
5 Oct 2023, 9:11 pm by Patent Docs
Noonan -- In view of the unprecedented uncertainty in patent law generated by counter-doctrinal Supreme Court decisions over the past decade or so and a cowed Federal Circuit relegated to complaining that their hands are tied on most matters (even when acknowledging that the decisions they are rendering do violence to the U.S. patent system; see now-Chief Judge Moore's dissent in Athena Diagnostics, Inc. v. [read post]
13 Apr 2019, 9:59 pm by Patent Docs
MBHB attorneys and Patent Docs authors Kevin Noonan and Donald Zuhn, and MBHB attorneys Josh Rich, Lisa Hillman, Sarah Fendrick, John Conour, Nate Chongsiriwatana, and Nicole Grimm will provide presentations on the following topics: • Updates on Subject Matter Eligibility Analysis • Patenting Repurposed Drugs • Antibody Patenting after Amgen v. [read post]
30 Jun 2016, 9:03 am by Jon Sands
  It doesn't matter, ruled the trial court. [read post]
13 Mar 2021, 8:05 pm by Patent Docs
In this presentation, MBHB attorney and Patent Docs author Kevin Noonan and MBHB attorney and Patent Docs contributor Bryan Helwig will discuss the following patent and IP law related topics: • Basics of virology and vaccines • SARS-CoV-2 (COVID) • Vaccines generally • COVID vaccines in development • Patent matters • Patent Licensing (compulsory and otherwise) • Vaccine availability and accessibility • Politics • Future prospects… [read post]
9 Jul 2012, 9:59 pm by Patent Docs
(For the sake of full disclosure, the IPO brief was co-authored by Patent Docs author Kevin Noonan.) [read post]
28 Jul 2011, 9:59 pm by Patent Docs
Noonan -- As discussed yesterday, a panel of the Federal Circuit seemingly expanded the scope of the written description requirement in its Boston Scientific Corp. v. [read post]
28 Mar 2012, 11:16 am
And I agree, at least as a practical matter. [read post]